Cutaneous Manifestations of Hydroxyurea Therapy in Childhood Case Report and Review

Pediatric Dermatology

Volumn 21, Issue 2, 2004, Pages 124-127

  Issaivanan, M ^a   Mitu, P Shrikande ^a,b   Chakrabarti, Manisha ^a   Khairkar, Praveen ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ALOPECIA; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG INDICATION; DRUG WITHDRAWAL; HUMAN; HYPERPIGMENTATION; LEG ULCER; LICHENOID ERUPTION; LONG TERM CARE; MALE; MYELOPROLIFERATIVE DISORDER; NAIL DISEASE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SICKLE CELL ANEMIA; SKIN MANIFESTATION; THALASSEMIA;

ANTINEOPLASTIC AGENTS; CHILD; HUMANS; HYDROXYUREA; HYPERPIGMENTATION; MALE; MOUTH MUCOSA; NAILS; TONGUE;

EID: 1942452799     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0736-8046.2004.21207.x     Document Type: Review

References (18)

1. Boyd AS, Neldner KH. Hydroxyurea therapy. J Am Acad Dermatol 1991;25:518-524.
2. Zachary KC, Davis B. Hydroxyurea for HIV infections. AIDS Clin Care 1998;10:25-27.
3. Romanelli F, Pomeroy C, Smith KS. Hydroxyurea to inhibit human immunodeficiency virus - I replication. Pharmacotherapy 1999;19:196-204.
4. Vichinsky EP. Hydroxyurea in children. Present and future. Semin Hematol 1997;34:22.
5. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975;111:183-187.
6. Vom-vouras S, Pakula AS, Shaw JM. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol 1991;24:1016-1017.
7. Cakir B, Sucak G, Haznedar R. Longitudinal pigmented nail bands during hydroxyurea therapy. Int J Dermatol 1997;36:236-237.
8. Delmas-Marsalet B, Beaulieu P, Tillet-Thiebaud F, Jary L, Teillet F. Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature. Nouv Rev Fr Hematol 1995;37:205-210.
9. Gropper CA, Don PC, Sadjadi MM. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythaemia vera. Int J Dermatol 1993;32:731-733.
10. Hernandez-Martin A, Ros Forteza S, de-Unamuno P. Longitudinal, transverse and diffuse nail hyperpigmentation induced by hydroxyurea. J Am Acad Dermatol 1999;40:333-334.
11. Kelsey PR. Multiple longitudinal pigmented bands during hydroxyurea therapy. Clin Lab Hematol 1992;14:337-338.
12. Kwong YL. Hydroxyurea induced nail pigmentation. J Am Acad Dermatol 1996;35:275-276.
13. Aste N, Fumo G, Contu F, Aste N, Biggio P. Nail pigmentation caused by hydroxyurea: report of 9 cases. J Am Acad Dermatol 2002;47:146-147.
14. de-Montalembert M, Belloy M, Bernaudin F, et al. Three years follow-up of hydroxyurea treatment in several ill children with sickle cell disease. J Pediatr Hematol Oncol 1997;19:313-318.
15. Sulis E, Floris C. Nail pigmentation following cancer chemotherapy: a new genetic entity? Eur J Cancer 1980;16:1517-1519.
16. Hendrix JD, Greer KE. Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol 1992;31:458-465.
17. Laughon SK, Shinn LL, Nunley JR. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV infected patient. Int J Dermatol 2000;39:928-931.
18. Baran R, Kechijan P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol 1989;21:1165-1175.